Table 3.

Test results for U.S. vancomycin for injection suppliers

Source	Lot no.	Sample details	Method (calculations based on area %)
			BP-HPLC				OTR-UPLC
			% vancomycin B	% total impurities	% largest impurity	% CDP-1 (maximum amt)	% vancomycin B	% total impurities	% largest impurity	% CDP-1 (maximum amt)
Sandoz Incorporated	AY1780	1-g vial	93	7	1.4	1.8	94	6	1.5	1.1
Baxter Health Care Corporation	NC063966	1-g intravenous bag					92	8	1.7	0.3
	2G3552	200-ml intravenous bag	95	5	2.0	0.6
Hospira Inc.	923103A	1-g vial	90	10	0.5	1.4	89	11	1.7	0.5
APP Pharmaceuticals LLC	6100850	1-g vial	94	6	1.9	1.2
	6100475						93	7	1.5	None detected
Bioniche Pharma USA LLC	10F13112A	1-g vial					93	7	1.6	0.2
	10H18782A		94	6	1.2	2.0
Akorn Strides, LLC	7004195	1-g vial					91	9	2.0	0.6
	7004471		94	6	1.1	1.9